Target intelligence / Profile preview

Contactin-3 (CNTN3)

Target
CNTN3
Molecular classification
Immunoglobulin superfamily cell adhesion molecule, GPI-anchored protein, Neural cell adhesion molecule, Other
01

Overview

Contactin-3 (CNTN3) is a member of the contactin subfamily of neural immunoglobulin (Ig) domain-containing cell adhesion molecules. It is located on the cell surface by a glycosylphosphatidylinositol (GPI) anchor and features an extracellular domain with six N-terminal Ig domains and four fibronectin type III domains. CNTN3 is mainly expressed in the nervous system and is involved in mediating cell surface interactions important for neuronal network growth, axon guidance, and brain development. While less studied than other contactin family members, it has been genetically implicated in neurodevelopmental disorders such as autism spectrum disorders. CNTN3 interacts with neuronal cell adhesion molecules and receptor protein tyrosine phosphatases, potentially as part of higher-order signaling complexes, but its distinct functional consequences are not fully elucidated. Currently, it is not regarded as a direct therapeutic target, and there are no known drugs that specifically modulate CNTN3.

Other names
Contactin 3CNTN3KIAA1496PANGBIG-1Brain-derived immunoglobulin superfamily protein 1Plasmacytoma-associated neuronal glycoproteinPCScontactin-3contactin 3 (plasmacytoma associated)
02

Biological functions

Cell adhesionNervous system developmentNeurite outgrowthSignal transduction (via interaction with other receptors/proteins)Neuronal network formation
03

Disease associations

Neurodevelopmental disorder (including autism spectrum disorder)Other (implicated in Juxtacortical chondrosarcoma per genetic association)

Beyond the preview

Go deeper on Contactin-3 (CNTN3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Contactin-3 (CNTN3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call